This is a Notice of Intent to award a sole-source, firm-fixed price contract to Genedata (USA) Inc. for required software/services, as the government believes only this vendor can satisfy the requirement. The period of performance is from March 30, 2026, to March 29, 2027. The work supports the National Institute of Allergy and Infectious Diseases' research on viral pathogens like SARS-CoV-2 and influenza. While not a solicitation, interested vendors may submit a capability statement for government consideration.